Bicalutamide (Casodex®) in the treatment of prostate cancer

@article{Fradet2004BicalutamideI,
  title={Bicalutamide (Casodex®) in the treatment of prostate cancer},
  author={Y. Fradet},
  journal={Expert Review of Anticancer Therapy},
  year={2004},
  volume={4},
  pages={37 - 48}
}
  • Y. Fradet
  • Published 2004
  • Medicine
  • Expert Review of Anticancer Therapy
Prostate cancer is an important healthcare issue in men worldwide. With the advent of prostate-specific antigen screening and improved diagnostic techniques, prostate cancer is now being diagnosed in younger men and at earlier disease stages. As a result, patients often live with their disease for many years after diagnosis. This shift in the patient profile has focused attention to the impact of treatment on quality of life. Medical/surgical castration has traditionally been the mainstay of… Expand
70 Citations
Striving Toward a Cure for Prostate Cancer.
  • M. Stein, T. Jang
  • Medicine
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2016
  • 5
  • PDF
Bicalutamide-induced hepatotoxicity: A rare adverse effect
  • 13
Structural basis for antagonism and resistance of bicalutamide in prostate cancer
  • 319
  • PDF
1,4-Substituted Triazoles as Nonsteroidal Anti-Androgens for Prostate Cancer Treatment.
  • 20
MDM2 antagonists boost antitumor effect of androgen withdrawal: implications for therapy of prostate cancer
  • 31
Nonsurgical management of hyperadrenocorticism in ferrets.
  • 5
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 96 REFERENCES
Bicalutamide for advanced prostate cancer: the natural versus treated history of disease.
  • 173
Bicalutamide monotherapy versus flutamide plus goserelin in prostate cancer patients: results of an Italian Prostate Cancer Project study.
  • 139
...
1
2
3
4
5
...